OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological characterization of GPR55, a putative cannabinoid receptor
Haleli Sharir, Mary E. Abood
Pharmacology & Therapeutics (2010) Vol. 126, Iss. 3, pp. 301-313
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

The Endocannabinoid System and the Brain
Raphael Mechoulam, Linda A. Parker
Annual Review of Psychology (2012) Vol. 64, Iss. 1, pp. 21-47
Closed Access | Times Cited: 988

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552

International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
Anthony P. Davenport, S P H Alexander, Joanna L Sharman, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 3, pp. 967-986
Open Access | Times Cited: 304

Phytocannabinoids as novel therapeutic agents in CNS disorders
Andrew J. Hill, Claire Williams, Benjamin J. Whalley, et al.
Pharmacology & Therapeutics (2011) Vol. 133, Iss. 1, pp. 79-97
Open Access | Times Cited: 299

Molecular Pharmacology of Phytocannabinoids
Sarah E. Turner, Claire Williams, Leslie L. Iversen, et al.
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2017), pp. 61-101
Closed Access | Times Cited: 231

Cannabis use during pregnancy: Pharmacokinetics and effects on child development
Kimberly S. Grant, Rebekah Petroff, Nina Isoherranen, et al.
Pharmacology & Therapeutics (2017) Vol. 182, pp. 133-151
Open Access | Times Cited: 211

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
Caroline Turcotte, François Chouinard, Julie Lefebvre, et al.
Journal of Leukocyte Biology (2015) Vol. 97, Iss. 6, pp. 1049-1070
Closed Access | Times Cited: 207

Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Kazuhito Tsuboi, Toru Uyama, Yasuo Okamoto, et al.
Inflammation and Regeneration (2018) Vol. 38, Iss. 1
Open Access | Times Cited: 187

The proposed mechanisms of action of CBD in epilepsy
Royston A. Gray, Benjamin J. Whalley
Epileptic Disorders (2020) Vol. 22, Iss. S1
Open Access | Times Cited: 166

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
Roberto Piñeiro, Tania Maffucci, Marco Falasca
Oncogene (2010) Vol. 30, Iss. 2, pp. 142-152
Closed Access | Times Cited: 210

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
Nariman Balenga, Elma Aflaki, Julia Kargl, et al.
Cell Research (2011) Vol. 21, Iss. 10, pp. 1452-1469
Open Access | Times Cited: 187

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Antonia Serrano, Loren H. Parsons
Pharmacology & Therapeutics (2011) Vol. 132, Iss. 3, pp. 215-241
Open Access | Times Cited: 173

Cannabinoid receptors: nomenclature and pharmacological principles
Linda Console‐Bram, Jahan P. Marcu, Mary E. Abood
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 38, Iss. 1, pp. 4-15
Open Access | Times Cited: 159

An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales, Patricia H. Reggio
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 265-273
Open Access | Times Cited: 152

Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
Christopher M. Henstridge, Nariman Balenga, Julia Kargl, et al.
Molecular Endocrinology (2011) Vol. 25, Iss. 11, pp. 1835-1848
Open Access | Times Cited: 149

Palmitoylethanolamide in CNS health and disease
Giuseppina Mattace Raso, Roberto Russo, Antonio Calignano, et al.
Pharmacological Research (2014) Vol. 86, pp. 32-41
Closed Access | Times Cited: 136

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Sandeep Vasant More, Dong‐Kug Choi
Molecular Neurodegeneration (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 133

Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption
Maurício dos Santos Pereira, Franscisco S. Guimarães, Elaine Aparecida Del Bel, et al.
Glia (2019) Vol. 68, Iss. 3, pp. 561-573
Closed Access | Times Cited: 131

Current evidence of cannabinoid‐based analgesia obtained in preclinical and human experimental settings
Jörn Lötsch, Iris Weyer-Menkhoff, Irmgard Tegeder
European Journal of Pain (2017) Vol. 22, Iss. 3, pp. 471-484
Open Access | Times Cited: 114

GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination
Chia‐Shan Wu, Hongmei Chen, Hao Sun, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e60314-e60314
Open Access | Times Cited: 105

GPR55 – a putative “type 3” cannabinoid receptor in inflammation
Hye-Won Yang, Juan Zhou, Christine Lehmann
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 3, pp. 297-302
Open Access | Times Cited: 97

Endocannabinoid system and pregnancy
Fernando Morgan de Aguiar Corrêa, Manuel L. Wolfson, P. Valchi, et al.
Reproduction (2016) Vol. 152, Iss. 6, pp. R191-R200
Open Access | Times Cited: 88

Brain activity of anandamide: a rewarding bliss?
María Scherma, Paolo Masia, Valentina Satta, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 309-323
Open Access | Times Cited: 86

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59

The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress
Sinemyiz Atalay, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Redox Biology (2022) Vol. 57, pp. 102489-102489
Open Access | Times Cited: 54

Page 1 - Next Page

Scroll to top